You are here

Article Text

Article menu
Download PDFPDF
Epilogue
Newborn with hydrops fetalis and a severe supraventricular arrhythmia
  1. Elena Battistuz1,
  2. Laura Travan2,
  3. Jenny Bua2,
  4. Antonella Trappan2,
  5. Francesca Galdo2,
  6. Marco Bobbo2,
  7. Egidio Barbi1,2,
  8. Francesco Maria Risso2
  1. 1 University of Trieste, Trieste, Italy
  2. 2 IRCCS materno infantile Burlo Garofolo, Trieste, Italy
  1. Correspondence to Dr Elena Battistuz, University of Trieste, Trieste 34125, Italy; elenabattistuz{at}gmail.com

https://doi.org/10.1136/archdischild-2019-317410

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    A 33+1-week female baby was born by caesarean section for worsening hydrops fetalis (HF) detected in the third trimester of pregnancy. Prenatal ultrasound showed a moderate enlargement of the right heart sections with a mild tricuspid insufficiency, without tachycardia, polyhydramnios, placentamegaly, renal agenesis and oesophageal atresia. At delivery, she developed transient hypotonia and apnoea and received nasal continuous positive airway pressure. Physical examination showed tachypnoea (70 breaths/min) and a moderate generalised subcutaneous oedema. Chest X-ray showed a cardiothoracic index of 0.82.

    At 90 min of life, her heart rate was 200–250 per minute. An ECG showed a paroxysmal supraventricular tachycardia (PSVT) with narrow complexes (figure 1). Vagal manoeuvres and five boluses of adenosine (250 μg/kg/dose) were ineffective, but she responded to amiodarone. Echocardiography showed severe tricuspid insufficiency and dilated right cardiac chambers. The baby presented further transient PSVT episodes, but these gradually improved on amiodarone, hydrochlorothiazide, spironolactone and furosemide. A primitive tricuspid valvulopathy with heart failure secondary to PSVT was diagnosed. …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Patient consent for publication Obtained.